Shengping Li
Impact in
- Biotechnology top 2%
- Microbial Inactivation Methods
- Oncology top 5%
- Pancreatic and Hepatic Oncology Research
- Cancer Immunotherapy and Biomarkers
Papers in
- Oncology 42
- Pancreatic and Hepatic Oncology Research 31
- Cancer Immunotherapy and Biomarkers 8
-
- RNA modifications and cancer 6
- Co-authors
- Chaobin He (31 shared papers)Xiaojun Lin (17 shared papers)Shuxin Sun (15 shared papers)Xin Huang (15 shared papers)Yu Zhang (9 shared papers)Xiang‐Ming Lao (9 shared papers)Yize Mao (15 shared papers)Alfred E. Chang (2 shared papers)
- Journals
- Frontiers in Oncology (7 papers)Journal of Inflammation Research (4 papers)BMC Cancer (4 papers)Pancreatology (3 papers)Journal of Cancer (3 papers)
- Partner nations
- ChinaUnited StatesCzechia
In The Last Decade
Shengping Li
83 papers receiving 1.7k citations
Peers
Comparison fields: 5 of 107
- Biotechnology 228
- Oncology 680
- Hepatology 171
- Cancer Research 315
- Immunology 361
Countries citing papers authored by Shengping Li
This map shows the geographic impact of Shengping Li's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shengping Li with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shengping Li more than expected).
Fields of papers citing papers by Shengping Li
This network shows the impact of papers produced by Shengping Li. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shengping Li. The network helps show where Shengping Li may publish in the future.
Co-authors
The 25 scholars most cited alongside Shengping Li, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 84 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2011 | 123 | |
| 2 | 2012 | 93 | |
| 3 | 2017 | 83 | |
| 4 | 2011 | 68 | |
| 5 | 2012 | 64 | |
| 6 | 2013 | 64 | |
| 7 | 2020 | 60 | |
| 8 | 2020 | 59 | |
| 9 | 2021 | 56 | |
| 10 | 2013 | 50 | |
| 11 | 2015 | 48 | |
| 12 | 2018 | 41 | |
| 13 | 2012 | 40 | |
| 14 | 2019 | 39 | |
| 15 | 2021 | 36 | |
| 16 | 2016 | 34 | |
| 17 | 2011 | 32 | |
| 18 | 2021 | 32 | |
| 19 | 2018 | 32 | |
| 20 | 2019 | 29 |
About Shengping Li
Shengping Li is a scholar working on Oncology, Molecular Biology, Surgery, Epidemiology and Biotechnology, having authored 84 papers that have together received 1.7k indexed citations. Recurring topics across this work include Pancreatic and Hepatic Oncology Research (31 papers), Microbial Inactivation Methods (15 papers), Cholangiocarcinoma and Gallbladder Cancer Studies (10 papers), Neuroendocrine Tumor Research Advances (9 papers), Cancer Immunotherapy and Biomarkers (8 papers), Cancer Genomics and Diagnostics (6 papers), RNA modifications and cancer (6 papers) and Hepatocellular Carcinoma Treatment and Prognosis (5 papers). The work is most often cited by research in Biotechnology (228 citations), Oncology (680 citations), Hepatology (171 citations), Cancer Research (315 citations) and Immunology (361 citations). Shengping Li has collaborated with scholars based in China, United States and Czechia. Frequent co-authors include Chaobin He, Xiaojun Lin, Shuxin Sun, Xin Huang, Yu Zhang, Xiang‐Ming Lao, Yize Mao, Alfred E. Chang, Hua Tang and Zhiyuan Cai. Their work appears in journals such as Frontiers in Oncology, Journal of Inflammation Research, BMC Cancer, Pancreatology and Journal of Cancer.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.